The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: Suppression of angiotensin II/AT1 signaling

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Li, Yuhao ^b   He, Lan ^a   Qi, Yanfei ^b   Rong, Xianglu ^c   Jiang, Jianmin ^a   Yang, Qinglin ^d   Yamahara, Johji ^e   Murray, Michael ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d UNIVERSITY OF ALABAMA   (United States)

^e Pharmafood Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANTIDIABETIC AGENT; AYURVEDIC DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; MANGIFERIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SALACIA OBLONGA EXTRACT; SERUM ALBUMIN; TELMISARTAN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; URIC ACID;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RENAL FIBROSIS; DRUG MECHANISM; HYPOALBUMINEMIA; KIDNEY FIBROSIS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLANT ROOT; PRIORITY JOURNAL; RAT; SALACIA; SALACIA OBLONGA; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 80052655766     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nep095     Document Type: Article

References (38)

1. Wynn T. A., Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases The Journal of Clinical Investigation 2007 117 3 524 529 (Pubitemid 46348506)
2. Gilbert R. E., Cooper M. E., The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney International 1999 56 5 1627 1637 (Pubitemid 29518163)
3. Steffes M. W., Osterby R., Chavers B., Mauer M., Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients Diabetes 1984 38 1077 1081 (Pubitemid 19250390)
4. Bader R., Bader H., Grund K. E., Mackensen-Haen S., Christ H., Bohle A., Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters Pathology, Research Practice 1980 167 204 216 (Pubitemid 10081929)
5. Lane P. H., Steffes M. W., Fioretto P., Mauer S. M., Renal interstitial expansion in insulin-dependent diabetes mellitus Kidney International 1993 43 3 661 667 (Pubitemid 23071950)
6. Taft J. L., Nolan C. J., Yeung S. P., Hewitson T. D., Martin F. I. R., Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria Diabetes 1994 43 8 1046 1051 (Pubitemid 24230711)
7. Mezzano S. A., Ruiz-Ortega M., Egido J., Angiotensin II and renal fibrosis Hypertension 2001 38 3 635 638
8. Zhao W., Chen S. S., Chen Y., Ahokas R. A., Sun Y., Kidney fibrosis in hypertensive rats: role of oxidative stress American Journal of Nephrology 2008 28 4 548 554 (Pubitemid 351832441)
9. Nakamura T., Takahasi T., Fukui M., Ebihara I., Osada S., Tomino Y., Koide H., Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats Journal of the American Society of Nephrology 1995 5 1492 1497
10. Ray P. E., Bruggeman L. A., Horikoshi S., Aguilera G., Klotman P. E., Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to AT1 receptors Kidney International 1994 45 1 177 184 (Pubitemid 24046006)
11. Iwano M., Neilson E. G., Mechanisms of tubulointerstitial fibrosis Current Opinion in Nephrology and Hypertension 2004 13 3 279 284 (Pubitemid 38582300)
12. Patwardhan B., Warude D., Pushpangadan P., Bhatt N., Ayurveda and traditional Chinese medicine: a comparative overview Evidence-Based Complementary and Alternative Medicine 2005 2 4 465 473 (Pubitemid 41752482)
13. Cooper E. L., Ayurveda is embraced by eCAM Evidence-Based Complementary and Alternative Medicine 2008 5 1 1 2 (Pubitemid 351301965)
14. Cooper E. L., Ayurveda and eCAM: a closer connection Evidence-Based Complementary and Alternative Medicine 2008 5 2 121 122 (Pubitemid 351786677)
15. Chandrasena J. P. C., The Chemistry and Pharmacology of Ceylon and Indian Medicinal Plants 1935 Colombo, Sri Lanka HC Press
16. Li Y., Huang T. H.-W., Yamahara J., Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity Life Sciences 2008 82 21-22 1045 1049
17. McKay D. L., Blumberg J. B., A review of the bioactivity of South African herbal teas: rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) Phytotherapy Research 2007 21 1 1 16 (Pubitemid 46173902)
18. Huang T. H.-W., Peng G., Li G. Q., Yamahara J., Roufogalis B. D., Li Y., Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR- Toxicology and Applied Pharmacology 2006 210 3 225 235 (Pubitemid 43107565)
19. Li Y., Peng G., Li Q., Wen S., Hsun-Wei Huang T., Roufogalis B. D., Yamahara J., Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker rats Life Sciences 2004 75 14 1735 1746 (Pubitemid 38961797)
20. Huang T. H., Yang Q., Harada M., Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes Toxicology and Applied Pharmacology 2006 210 78 85 (Pubitemid 41790554)
21. Huang TH, He L, Qin Q, Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor Diabetes, Obesity and Metabolism 2008 10 574 585 (Pubitemid 351850901)
22. Yoshikawa M., Nishida N., Shimoda H., Takada M., Kawahara Y., Matsuda H., Polyphenol constituents from salacia species: quantitative analysis of mangiferin with -glucosidase and aldose reductase inhibitory activities Yakugaku Zasshi 2001 121 5 371 378 (Pubitemid 32440588)
23. Li Y., Kishimoto I., Saito Y., Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protection mechanism in the heart Circulation 2002 106 1722 1728
24. Singh R., Alavi N., Singh A. K., Leehey D. J., Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation Diabetes 1999 48 10 2066 2073 (Pubitemid 29458373)
25. Chouinard R. F., Meek R. L., Cooney S. K., Tuttle K. R., Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors Kidney International 2002 61 1 S106 S109
26. Tsuchiya T., Shimizu H., Shimomura K., Mori M., Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells American Journal of Nephrology 2003 23 4 222 228 (Pubitemid 36980718)
27. Li Y., Qi Y., Kim M. S., Xu K. Z.-Y., Huang T. H.-W., Rong X., Murray M., Yamahara J., Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats Diabetes/Metabolism Research and Reviews 2008 24 6 498 506
28. Xu Z.-G., Lanting L., Vaziri N. D., Li Z., Sepassi L., Rodriguez-Iturbe B., Natarajan R., Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese zucker rat kidney: reversal by angiotensin II type 1 receptor blockade Circulation 2005 111 15 1962 1969 (Pubitemid 40570216)
29. Remuzzi G., Benigni A., Remuzzi A., Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes The Journal of Clinical Investigation 2006 116 2 288 296 (Pubitemid 43228342)
30. Lund L. R., Riccio A., Andreasen P. A., Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen-activator inhibitor messenger-RNAinWi-38 human lung fibroblasts The EMBO Journal 1987 6 1281 1286
31. Ruiz-Ortega M., Rupérez M., Esteban V., Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrology Dialysis Transplantation 2006 21 16 20 (Pubitemid 43057101)
32. Wolf G., Haberstroh U., Nielson E. G., Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells American Journal of Pathology 1992 140 95 107
33. Kagami S., Border W. A., Miller D. E., Noble N. A., Angiotensin II stimulated extracellular matrix protein synthesis through induction of transforming growth factor-b expression in rat glomerular cells The Journal of Clinical Investigation 1994 93 2431 2437 (Pubitemid 24177156)
34. Singh R., Alavi N., Singh A. K., Leehey D. J., Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation Diabetes 1999 48 10 2066 2073 (Pubitemid 29458373)
35. Wolf G., Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor- pathway Kidney International 2006 70 11 1914 1919 (Pubitemid 44863378)
36. Eddy A. A., Plasminogen activator inhibitor-1 and the kidney American Journal of Physiology 2002 283 2 F209 F220
37. Fogo A. B., Renal fibrosis: not just PAI-1 in the sky The Journal of Clinical Investigation 2003 112 326 328 (Pubitemid 38063760)
38. Deatrick K. B., Eliason J. L., Lynch E. M., Moore A. J., Dewyer N. A., Varma M. R., Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model Journal of Vascular Surgery 2005 42 140 148 (Pubitemid 40966087)